期刊文献+

VEGF,IL-6,leptin水平测定在2型糖尿病患者房水中的临床意义 被引量:1

Levels of VEGF,IL-6,leptin in the aqueous humor of patients with type 2 diabetes
下载PDF
导出
摘要 目的:检测2型糖尿病患者眼房水中血管内皮生长因子(vascular endothelial growth factor,VEGF)、白细胞介素-6(interleukin-6,IL-6)和瘦素(leptin)的含量,并探讨其临床意义。方法:对70例70眼2型糖尿病患者房水中VEGF和IL-6的含量采用双抗体夹心酶联免疫吸附法检测,leptin含量采用放射免疫法检测。根据散瞳眼底检查和眼底荧光素血管造影检查,将实验组分为:无糖尿病性视网膜病变组22例22眼、单纯型糖尿病性视网膜病变组28例28眼、增生型糖尿病性视网膜病变组20例20眼,对照组为健康的老年性白内障患者20例20眼。结果:3组房水VEGF的含量分别为(250.32±26.77),(300.11±58.89),(496.23±91.06)ng/L,IL-6含量分别为(162.81±33.92),(256.76±64.15),(391.27±90.46)ng/L,leptin含量分别为(69.80±21.37),(155.08±32.76),(230.27±56.92)ng/L,对照组房水VEGF含量为(144.69±26.55)ng/L、IL-6含量为(86.71±22.69)ng/L,leptin含量为(43.62±20.02)ng/L,对照组与实验组比较差异均有统计学意义(F=118.62,P<0.01;F=110.53,P<0.01;F=101.22,P<0.01)。对照组、NDR,BDR与PDR组房水VEGF,IL-6,leptin含量有依次增加的趋势。房水中VEGF与IL-6,leptin含量有相关性(r=0.995,P<0.01;r=0.776,P<0.01);房水中VEGF,IL-6,leptin含量与糖尿病患者的病程及糖尿病性视网膜病变的严重程度有相关性(r=0.722,P<0.01;r=0.716,P<0.01)(r=0.869,P<0.01;r=0.865,P<0.01)(r=0.776,P<0.01;r=0.765,P<0.01)。结论:VEGF,IL-6,leptin在糖尿病性视网膜病变的形成过程中有重要作用,且VEGF与IL-6,VEGF与leptin之间有相关性。 AIM: To assay the contents of vascular endothelial growth factor (VEGF), interleukin-6 (IL-6) and leptin in the aqueous humor of patients with type 2 diabetes and to explore their roles in the pathogenesis of diabetic retinopathy (DR). METHODS: The contents of VEGF and IL-6 in the aqueous humor of 70 patients (70 eyes) with type 2 diabetes were determined by ELISA technique, and the content of leptin was determined by radioimmunoassay. According to the fundus examination after mydriasis and fundus fluo-resecein angiography, experimental groups include 22 cases (22 eyes) without diabetic retinopathy, 28 cases (28 eyes) with simple diabetic retinopathy and 20 cases (20 eyes) with proliferative diabetic retinopathy. The control group include 20 cases (20 eyes) with senile cataract. RESULTS: The contents of VEGF in the aqueous humor of three experimental groups were (250. 32 ± 26. 77 ), (300.11 ± 58.89), (496.23 ± 91.06) ng/L respectively; the contents of IL-6 were (162.81 ± 33.92), (256.76 ± 64.15), (391.27 ± 90.46)ng/L respectively; the contents of leptin were (69.80 ± 21.37), ( 155.08 ± 32.76 ), ( 230.27 ± 56.92 ) ng/L respectively. In the control group, the contents of VEGF,IL-6 and leptin in the aqueous humor were respectively( 144.69 ± 26.55 ) ng/L, ( 86.71 ± 22.69 ) ng/L, (43.62 ± 20.02) ng/L. There were statistically significant differences between control group and experimental groups (F=118.62,P〈0.01;F=110.53,P〈0.01;F=101.22, P〈0.01). The levels of VEGF, IL-6, leptin in the aqueous humor were increased in turn in control group, non-diabetic retinopathy (NDR)group, background diabetic retinopathy (BDR) group and proliferative diabetic retinopathy (PDR) group. The level of VEGF was significantly correlated with the levels of IL-6, leptin in the aqueous humor ( r = 0.995, P 〈 0.01 ; r = 0. 776, P 〈 0.01 ) ; the contents of VEGF,IL-6, and leptin in the aqueous humor were also significantly correlated with the course of diabetes and severity of diabetic retinopathy ( r = 0. 722, P 〈 0.01 ; r = 0. 716, P〈0.01 ) ( r = 0.869,P〈 0.01 ,r=0.865, P〈 0.01 ) ( r = 0.776,P 〈 0.01 ; r = 0.765,P〈 0.01 ). CONCLUSION: VEGF, IL-6, and leptin play active roles in the generation and development of DR, and the level of VEGF in the aqueous humor closely correlates with the level of IL-6 and leptin in the aqueous humor of diabetic patients.
出处 《国际眼科杂志》 CAS 2008年第2期323-325,共3页 International Eye Science
关键词 2型糖尿病 视网膜病变 血管内皮生长因子 白细胞介素-6 瘦素 vascular endothelial growth factor interleukin-6 leptin diabetic retinopathy type 2 diabetes
  • 相关文献

参考文献14

二级参考文献102

  • 1胡春玲,陈维,惠延年.早期糖尿病大鼠视网膜中MMP-3和VEGF表达的意义[J].国际眼科杂志,2004,4(4):615-617. 被引量:10
  • 2李媛,卢艳.糖尿病视网膜病变早期发病机制研究进展[J].国际眼科杂志,2005,5(4):750-754. 被引量:40
  • 3朱鸿,施彩虹.糖尿病视网膜病变的相关诊断技术展望[J].国际眼科杂志,2005,5(5):1016-1019. 被引量:33
  • 4张小玲,邱曙东,陈艳炯,孙文涛.糖尿病性视网膜病变发病机制研究进展[J].国际眼科杂志,2005,5(6):1239-1242. 被引量:59
  • 5Dorey CK, Aouididi S, Reynaud X, Dvorak HF, Brown LF. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol, 1996; 114:1210
  • 6Sato Y, Kanno S, Oda N, Abe M, Ito M, Shitara K, Shibuya M. Properties of two VEGF receptors, Flt-1 and KDR in signal transduction. Ann NY Acad Sci, 2000;902:201
  • 7Kvanta A, Shen WY, Sarman S, Seregard S, Steen B, Rakoczy E. Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. Curr Eye Res, 2000;21(3):684-690
  • 8Lutty GA, McLeod DS, Merges C, Diggs A, Plouet J. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol,1996;114:791
  • 9Saghizadeh M, Brown DJ, Castellon R, Chwa M, Huang GH, Ljubimova JY,Rosenberg S, Spirin KS, Stolitenko RB, Adachi W, Kinoshita S, Murphy G,Windsor L J, Kenney MC, Ljubimov AV. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in
  • 10Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N,Adamis AP. vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol, 1996; 114:1219

共引文献132

同被引文献11

  • 1刘世全,朱秀安.胰岛素样生长因子Ⅰ基因在正常及糖尿病鼠眼组织中的表达[J].中华眼科杂志,1995,31(4):291-295. 被引量:10
  • 2李媛,卢艳.糖尿病视网膜病变早期发病机制研究进展[J].国际眼科杂志,2005,5(4):750-754. 被引量:40
  • 3张小玲,邱曙东,陈艳炯,孙文涛.糖尿病性视网膜病变发病机制研究进展[J].国际眼科杂志,2005,5(6):1239-1242. 被引量:59
  • 4樊小娟,张小玲.糖尿病视网膜病变发病机制中VEGF与PEDF的研究进展[J].国际眼科杂志,2007,7(2):485-488. 被引量:29
  • 5Clemmons DR, Moses AC, McKay MJ, et al. Rosen and John Ruckle. The combination of insulin-like growth factor 1 and insulin-like growth factor binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.J Clin Endocrinol Metab 2000:85,1518
  • 6Mathonnet M, Comte I, Lallou F, et al. insulin-like growth factor 1 induce survival axotomixeed of factory neurons in the chick. Neurosci Lett 2001 ;308(2) :667-671
  • 7Pe'er J, Shweiki D, Itin A, et al. Hypoxia-indueed expression of vascular endothelial growth factor by retinal cells is a common factor in neovaseularizing ocular diseases. Lab Invest 1995 ;75 (6) :638-643
  • 8Noma H, Funatsu H, Yamashita H, et al. Regulation of Angiogenesis in Diabetic Retinopathy.Arcb Ophthalmol 2002;120:1075-1080
  • 9Meyer-Schwickerath R, Pfeiffer A, Blum WF. Vitreous levels of the insulin-like Growth factors Ⅰ and Ⅱ , and the insulin-like growth factor binding proteins 2 and 3 increase in neovascular eye disease, Studies in non-diabetic and diabetic subjects.J Clin Invest 1993 ;92:2620-2625
  • 10James RS, Effects of insulin and IGF- Ⅰ on vascular smooth muscle glucose and cation metabolism, Diabetes 1996 ;45 ( suppl3 ) :47-52

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部